of DSEK over PK are that the host cornea remains structurally intact and more resistant to injury, intra-operative and post-operative suture management issues are non-existent, and concerns about late wound dehiscence after suture removal are virtually absent. Furthermore, the risk of expulsive intra-operative suprachoroidal hemorrhage is minimized because the wound is small and can be closed quickly. Of importance to the patient are the rapid visual recovery, minimal induced astigmatism, and relative safety of topical anesthesia. This article will provide a brief overview of DSEK, an elegant technique for selective replacement of dysfunctional corneal endothelium that is constantly evolving and rapidly revolutionizing corneal transplantation.
History
In 1998 in The Netherlands, Melles presented a significant advance in the way in which corneal transplants were performed for endothelial disease. Terry performed the first endothelial keratoplasty in the US in 2000, and called it deep lamellar endothelial keratoplasty (DLEK). 2 Melles modified his technique in 2002 by introducing a larger, folded posterior disc through a smaller self-sealing scleral tunnel incision. 3 The following year, Melles reported how a folded transplant insertion could be combined with removing the recipient endothelial layer by means of stripping Descemet's membrane, 4 a procedure now referred to as DSEK. 5 The technique further evolved when Gorovoy introduced the use of a microkeratome preparation of the donor graft instead of hand dissection and called it Descemet's stripping automated endothelial keratoplasty (DSAEK). 6 The preparation of donor tissue moved toward becoming truly automated when Cheng et al.
used a femtosecond laser for the first time in humans to prepare the posterior corneal disc in a standardized and fully automated fashion. Descemet Stripping with Endothelial Keratoplasty 
Surgical Technique
The DSEK surgical technique has been described previously in detail, and can be seen in video format. 11 The preparation of the donor lamellar disc with an artificial anterior chamber can be performed either manually, using dissecting blades, or in a semi-automatic fashion, using a hand-driven microkeratome. The posterior donor disc is trephined to an 8-9mm donor size and stored in a tissue storage solution while the recipient is prepared.
Difficulties with preparation of the donor tissue can be minimized by using Busin introduced a funnel-shaped instrument that curls the donor graft when it is being inserted through the wound into the anterior chamber.
We have actually inserted the device into the wound to minimize crush damage to the tissue while passing through the wound.
Air is then used to unfold the folded donor tissue slowly so that donor stroma sticks to recipient stroma. Once the donor is properly positioned by massaging the recipient corneal surface with a roller and draining fluid from the host-recipient interface via corneal stab incisions, the anterior chamber is filled with air for several minutes to push the donor graft up against the host stroma and encourage graft adhesion. The procedure is completed by removing some air from the anterior chamber and dilating the pupil to avoid pupillary block. 
Pre-operative Management Issues
DSEK was initially used for treatment of Fuchs' endothelial dystrophy, pseudophakic bullous keratopathy, and aphakic keratopathy. We have shown that it can also be used to treat corneal edema associated with iridocorneal endothelial syndrome; 13 it has also been shown to restore clarity to a failed prior penetrating graft. 14 in the mid-peripheral recipient cornea, 18 the dislocation rate fell to about 4%.
To reduce donor dislocations, selectively scraping the peripheral recipient bed has been found to increase donor edge adhesion. 19 An air-fluid exchange system has also been described to promote graft adhesion during DSEK. 20 The majority of graft dislocations occur very early in the first post-operative week.
An air injection procedure can be repeated to reattach a detached graft, 17 although spontaneous reattachments have been reported. preventing rejection, and following the endothelial cell count. In a recent study we conducted to determine whether DSEK affects Goldmann applanation tonometry IOP readings in non-hypertensive eyes, we found that changes in central corneal thickness were not significantly correlated with changes in IOP, and that Goldmann tonometry seems to be an adequate method of monitoring glaucoma and steroid-responsive IOP changes after DSEK.
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Visual recovery is quite rapid after DSEK compared with PK. Mean best spectacle-corrected visual acuity of 20/40 is generally achieved within three to six months of surgery. 17, 23 In addition, hard contact lenses are not required for best vision after DSEK because the corneal surface is minimally altered, whereas 10-15% of PK eyes often require a hard contact lens to normalize the corneal surface and achieve best vision.
DSEK causes very minimal changes in corneal surface topography, mean spherical equivalent refraction, and mean refractive cylinder-these are important advantages compared with standard PK. At most, some surgeons report the induction of a small mean hyperopic shift with DSEK, which can be factored into intraocular lens calculation nomograms. 5, 23 In addition, the relatively predictable refractive outcomes achieved with DSEK allow cataract extraction with intraocular lens implantation to be performed beforehand, thereby avoiding endothelial cell loss from subsequent surgical trauma. This represents a paradigm shift from PKs, which have such unpredictable refractive outcomes that cataract surgery is often postponed until afterward to help reduce induced refractive error.
A new European-American multicenter study reported a two-year incidence of graft rejection episodes of 7.5% in a combined series of nearly 200 DLEK and DSEK cases. 24 The two-year rejection rate observed after PK for similar cases in the Swedish Corneal Transplant Register was 13%. 25 An important consideration when comparing rejection rates between various types of corneal transplants is the post-operative steroid regimen that is employed.
The above multicenter study also showed that steroid usage differs significantly between DSEK and PK patients. Whereas almost all PK patients had stopped using steroid drops during their first post-operative year to encourage wound healing, 80% of DSEK/DLEK patients were still using topical steroid drops at two years because wound healing is not a major concern in endothelial keratoplasty. 24 Endothelial cell density has been a source of concern following endothelial keratoplasty 23 because DSEK involves greater manipulation of donor tissue than does PK. A recent report comparing endothelial cell density longitudinally after grafting revealed a mean cell count of 3,100 cells/mm 2 before surgery, 2,000 cells/mm 2 at six months, 1,900 cells/mm 2 at one year, and 1,800 cells/mm 2 at two years. 11 Although cell loss in the first post-operative year following DSEK was found to be higher than cell loss noted in a recent, separate PK series at the authors' center, it was found to be within the wide range that has been reported historically in various PK series. Of note is that the larger graft size often used in DSEK (9mm) transfers 26% more surface area of health donor endothelial cells in comparison with the graft size typically used in PK (8mm)-this may reduce the rate of cell loss over the long term. More importantly, this study showed that modifications to certain elements of the surgical technique were associated with reduced rates of endothelial cell loss. These modifications include using single-point fixation forceps, which compress the donor tissue only at the tip during graft insertion, and using a clear corneal incision rather than a scleral tunnel incision to insert donor tissue as there is less tissue compression associated with clear corneal incisions.
Conclusion
The evolution of endothelial keratoplasty over the past decade and the continued advances from around the world in both the transplantation of selective components of the cornea and the regeneration of human corneal endothelial cells have truly been remarkable. DSEK is fast becoming the favored way of treating endothelial dysfunction. The evolving surgical technique will undoubtedly produce faster visual recovery, a tectonically stronger eye, an improved safety profile, and, most importantly, a more satisfied patient. ■
